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E-mail address: okadak@recab.tut.ac.jpThe metabolic pathways in apicoplasts of human malaria parasites are promising drug targets. The
apicomplexan parasites exhibit delayed cell death when their apicoplast is impaired, but the meta-
bolic pathways within apicoplasts are poorly understood. A nuclear-encoded heme oxygenase (HO)-
like protein with an apicoplast-targeted bipartite transit peptide was identiﬁed in the Plasmodium
falciparum genome. Puriﬁed mature recombinant PfHO protein converted heme into bilirubin IXa
as conﬁrmed by high-performance liquid chromatography. In addition, PfHO required an iron che-
lator such as deferoxamine for complete activity. These observations lead to the conclusion that a
novel enzymatic heme degradation system is present in human malaria parasites.
 2008 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction phytes, pathogenic bacteria, cyanobacteria, red algae, and higherThe biosynthesis of bilirubin (BR) IXa from heme includes two
enzymatic steps. The ﬁrst step involves the opening of the tetra-
pyrrole macrocycle of protoheme to form biliverdin (BV) IXa; this
reaction is catalyzed by heme oxygenase (HO) [1,2]. The second
step involves the reduction of BV IXa to BR IXa. HO and BV reduc-
tase (BVR) have been identiﬁed in the cyanobacterium Synechocys-
tis sp. PCC 6803 [1,3]. However, BVR is absent from plant plastids.
Preliminary experiments using crude extracts of Plasmodium berg-
hei conﬁrmed the presence of HO and BVR activities in the cell free
extracts of this parasite [4]; however, the puriﬁed protein was not
characterized. The genomes of Plasmodium falciparum and P. berg-
hei lack the gene for BVR. The P. falciparum HO (PfHO) includes a
transit peptide that targets the gene product to plastids.
HO catalyzes the heme cleavage at the alpha methane bridge to
form BV IXa, thus releasing iron. Genes encoding HOs have been
isolated from various organisms, including mammals, crypto-chemical Societies. Published by E
, Thermosynechococcus elong-
obutylicum; BR, bilirubin; BV,
oxidoreductase; HO, heme
l-type Fe–S oxidoreductase;
6PDH, glucose-6-phosphate
atography; GB, GenBank; LB,plants [5]. In some pathogenic bacteria, HO is used to scavenge iron
from the host during infection [6], whereas in cyanobacteria, algae,
and higher plants, plastidial HOs are required for the synthesis of
the phycobilin chromophores for photosynthetic light harvesting
or for photoreceptors [7]. These different functions are reﬂected
in the difference in cellular locations and properties of the en-
zymes. In algae, cyanobacteria, and higher plants, HO is a soluble
enzyme. The plastidial HO requires reduced ferredoxin (Fd) to pro-
vide the electrons required for the reaction.
The enzymatic heme degradation system in protozoan parasites
of the phylum Apicomplexa is unknown. Here, I report that PfHO is
a novel double-barreled enzyme with HO and BVR activities. In
addition, the plastidial localization of this enzyme suggests that
Fd is the only electron donor.
I have puriﬁed recombinant PfHO using an Escherichia coli
expression system and characterized the reaction catalyzed by this
enzyme with Fd. The result of this study indicates that PfHO de-
pends on reduced Fd and a strong iron chelator for maximum activ-
ity. The possible interpretation of this ﬁnding is also presented.
2. Materials and methods
2.1. Reagents
Enzymes for DNA manipulation were purchased from New
England Biolabs; agar and organic nutrients for Luria-Bertani (LB)lsevier B.V. All rights reserved.
314 K. Okada / FEBS Letters 583 (2009) 313–319medium, from Difco; hemin, BV IXa, and BR IXa preparations used
as substrates and/or high-performance liquid chromatography
(HPLC) standards, from Frontier Scientiﬁc Inc. and SIGMA; HPLC-
grade acetone, ethanol, water, and acetic acid, from Nacalai Tesque.
2.2. Construction of the pET24bUncF-PfHO expression vector
Chemically synthesized HO gene (Supplementary material), the
mature ho gene without the predicted apicoplast-targeting signal
and transit peptide sequences, was subcloned into the E. coli
expression vector pET24b (+) (Novagen) to form pET24b-PfHO.
The HO gene was ampliﬁed using the primers PfHONdeIfwd
(50-AAAACATATGGCACTGTTCGTGCGCAATGAAGTGC-30) and
PfHOHisXhoIrev (50-TTTTCTCGAGTGATTTTACTTTTTCGAAATGTT-
TAGTC-30), which contained the NdeI and XhoI sites (underlined),
respectively, and was cloned into NdeI- and XhoI-digested pET24b
(+) to form pET24b-PfHO. The integrity of the construct was veri-
ﬁed by restriction analysis and DNA sequencing of the entire insert.
The pET24b-pfHO construct contained the HO gene under the con-
trol of the T7 promoter and formed HO protein containing the
hexahistidine (His6) tag at its C terminus. pAVD10 (Avidis) is de-
signed to provide the ATPase b subunit encoded by the uncF gene.
The digestion of pAVD10 with XbaI released the uncF coding se-
quence and its ribosome binding site, and this fragment was cloned
into XbaI-digested pET24b-PfHO to form pET24bUncF-PfHO.
2.3. Expression and puriﬁcation of recombinant PfHO
pET24bUncF-PfHO was transformed into E. coli strain C41 (DE3)
(Avidis). A fresh single colony of E. coli C41 (DE3) was transformed
with the plasmid expressing the His6-tagged PfHO protein and
cultured overnight at 37 C in 100 mL LB medium containing 1%
glucose and kanamycin (15 lg/mL). Eighty milliliters of this cul-
ture was incubated overnight and inoculated into 8 L LB medium.
E. coli C41 (DE3) containing pET24bUncF-PfHO was grown at
37 C in 8-L batches of LB medium containing kanamycin (15 lg/PfHO 1 MIRKIIILMFTFFSNIHNEKIYHHKQRRKFLKGPLGYLN
CaFeOR 1 ---------MELLKSDKNKILTHFNEVLKIKKRNL---N
PfHO 90 YHETHLFVRNEVLPTLAKIENENLKEKEKNKEIF-RN--
CaFeOR 75 CG--HYFGTN-MGDTLPKNSFYNQFLSEYNKYDFSKYPM
PfHO 170 GPMQLTNHLYDDIIYVSSVVENSDDVSPSEYCMEYISHL
CaFeOR 161 ---QISNILNDKIVEIGIGLETSND-KVREYCINKGFNF
PfHO 255 TYVADVENFEVSQKCFLHLLFCLNKMSRKWSRWEKDNFL
CaFeOR 245 TDIISLEPISIQKNTLVELLYT-NKLYDPPKGWIIKEIL
expression
PfHO 1 MIRKIIILMFTFFSNIHNEKIYHHKQRRKFLKGPLGY-LN
AtHO4 1 -------------------------MATSRLNASCRFPAS
PfHO 88 YNYHETHLFVR--NEVLPTLAKIENENLKEKEKNKEIFRN
AtHO4 64 AGEKPERRYPREPNGFVEEMRFVVMK-IHPRDQVKEGKSD
PfHO 174 LTNHLYDDIIYVSSV-VENSDDVSPSEYCMEYISHLENLC
AtHO4 153 RAENLSRDLEWFKEQGYEIPESMVPGK---AYSQYLKNIA
PfHO 262 NFEVSQKCFLHLLFCLNKMSRKWSRWEKDNFLASLHNATN
AtHO4 237 LSELLQNVSEEL----NKVAELWTREEKNHCLEETEKSFK
signal peptide
expression
A
B
Fig. 1. Comparison between the sequences of PfHO and AtHO4 and between those of PfH
[23]. Identical and similar residues are in black and gray boxes, respectively. The horizo
bipartite apicoplast-targeting signal showing N-terminal extensions resembling signal p
transit peptide and mature protein. The asterisk indicates an essential histidine residue.
The database (GenBank; GB) Accession numbers are AAN35314 for PfHO (PlasmoDB lo
CaFeOR.mL) until the optical density at 578 nm (OD578) increased to 0.6.
Protein expression was induced by the addition of 1 mM isopropyl-
thio-b-galactoside and incubation for 16 h at 20 C; subsequently,
the bacteria were harvested by centrifugation. The bacterial pellet
from 8 L culture was resuspended in 100 mL lysis buffer (50 mM
sodium phosphate, pH 7.4, 10 mM b-mercaptoethanol [b-Me],
300 mM NaCl, protease inhibitor cocktail [EDTA-free, 100; Naca-
lai Tesque, Osaka], and 5 mM imidazole), and the cells were lysed
by sonication for 30 s on ice. The cell debris was removed by cen-
trifugation for 30 min at 50000g. The resulting supernatant was
loaded directly onto a BD TALON superﬂow column (1.5  5 cm;
Clontech Laboratories Inc.) equilibrated with 10 column volumes
of lysis buffer at 4 C. Unbound protein was eliminated by washing
the column with 20 column volumes of lysis buffer. His6-tagged
PfHO protein was eluted with 50 mM sodium phosphate (pH 7.0)
containing 10 mM b-Me, 300 mM NaCl, and 150 mM imidazole.
Fractions containing His6-tagged PfHO were pooled and concen-
trated to 2 mL using an Amicon Ultra-15 unit with a 10-kDa
cut-off (Millipore). This fraction was rebuffered in 50 mM
HEPES–NaOH buffer (pH 7.5) containing 100 mM NaCl and
10 mM b-Me using prepacked Sephadex G-25 gel ﬁltration
columns NAP-10 (GE Healthcare UK Ltd.).
2.4. Preparation of recombinant Fd and ferredoxin-NADP+ reductase
(FNR)
Recombinant P. falciparum Fd (PfFd) as well as Thermosynecho-
coccus elongatus FNR (TeFNR) and Fd1 (TeFd1) were expressed
and puriﬁed as described previously [8,9].
2.5. Spectroscopic analysis of heme binding
PfHO was added to a 5-lM (ﬁnal concentration) hemin solution
in a ﬁnal volume of 500 lL of 50-mM HEPES–NaOH buffer (pH 7.5)
containing 100 mM NaCl and 2 mM deferoxamine (SIGMA).
Time-dependent absorbance changes were monitored during theRNVIQKKHYNLYAKK-FINYKEIQIQRINDYRKRSGVDKNNINYNLRDTYN
REFSFDKVANSTINKGYLNGSKID--RIIFYLRSTGCEWS-CTK-MGGCFM
INDYNS-N-FT-RQTFLQFLMDLYNIFLKIDDL---FLENKTYF-SILIYN
ICIYNAGSILNDNEIPREELYRILNVIKRNNDIKRVVLESRPEFINVEVLN
ENLCEENKL-----SFLAHAYVFYKNFHLSKEHLLKSICKYLNIIKKLKSS
KNYLEKVKLIKNYSNIKTLTYVTVKLLFLTIDESIRDV---IQTMKDLSGL
ASLHNATNKMMILTKHFE-KVKS
ANLHN-TN---LM-KNFELRIGG...
RNVIQKKHYNLYAKKF-INY-KEIQIQRINDYRKRSGVDKNNINYNLRDT
RRLDCESYVSLRAKTVTIRYVRTIAAPRRHLVR-RANEDQTLV-VNVVAA
INDY-NS-NFTRQTFLQFLMDLYNIFLKIDDLFLENKTYFSILIYNGPMQ
SNDLVSTWNFTIEGYLKFLVDSKLVFETLERIINESAIQAYAGLKNTGLE
EENKLSFLAHAYVFYKNF-HLSKEHLLKSICKYLNIIKKLKSSTYVADVE
EKDPPAFICHFYNI--NFAHSAGGRMIGTKVAE-KILDNKELEFYKWDGQ
KMMILTKHFEKVKS
FYWEIFRYLLS---
*
O and CaFeOR by pairwise alignment. The alignment was created by using BioEdit
ntal line indicates a possible signal peptide of PfHO. The PfHO precursor contains a
lus transit peptides. The arrow indicates the predicted cleavage sites between the
(A) PfHO and AtHO4. (B) PfHO and CaFeOR. The box indicates the conserved region.
cus PF10_0116), ABE65721 for AtHO4 (TAIR locus At1g58300), and NP_149336 for
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Fig. 2. PfHO binding to hemin as measured by absorbance spectroscopy. The
direction of the time-dependent spectral changes is indicated by the arrow. Inset,
spectrophotometric titration of PfHO: black rhombus, hemin with PfHO and white
triangle, hemin only.
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heme was monitored by absorption spectroscopy. Aliquots of heme
(2–8 lM) were added to the cuvette containing PfHO at 25 C.
Spectra were recorded after heme addition and the heme-binding
constant (Kd) was calculated from the difference in absorbance at
402 nm.0
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Fig. 3. Catalytic activity of PfHO. The direction of the spectral changes is indicated b
deferoxamine (2 mM). (B) Reactants as in A + NADPH (50 lM) + TeFNR (7.2 nM) + G6P
recorded after 2 min incubation. The Soret and the 680-nm bands appear and increase
recorded after the addition of TeFd1.2.6. HO and BVR assays
Fd-dependent HO activity was assayed in 500 lL of 50-mM
HEPES-NaOH buffer (pH 7.5) containing 2 mM deferoxamine,
50 lM NADPH, 1 mM glucose-6-phosphate (G6P), 0.5 units
glucose-6-phosphate dehydrogenase (G6PDH), 7.2 nM TeFNR,
2.4 lM Fd (TeFd1 or PfFd), 5 or 10 lM hemin or 5 lM BV IXa sub-
strate, and 10 or 20 lM PfHO. Assays were performed at room tem-
perature (25 C) and all reactions were initiated by Fd addition.
Heme and BV IXa reductions were monitored spectrophotometri-
cally using a Shimadzu UV-2500PC UV–Vis spectrophotometer.
2.7. High-performance liquid chromatography (HPLC) analyses
The products formed by the hemin reduction catalyzed by
recombinant His6-tagged PfHO were analyzed by HPLC on a
reverse-phase COSMOSIL 5C18-AR-II column (5 lm particle diame-
ter, 4.6  250 mm; Nacalai Tesque, Osaka), at 40 C, with a solvent
ﬂow rate of 0.75 mL/min. A 500-lL reaction mixture containing
30 lMHis6-tagged PfHO, 5 lM hemin, 50 mM HEPES–NaOH buffer
(pH 7.5), 2 mM deferoxamine, 100 mM NaCl, 50 lM NADPH,
2.4 lM PfFd, 7.2 nM TeFNR, 1 mM G6P, and 0.5 units G6PDH was
incubated at room temperature for 15 min. This mixture was
diluted with 500 lL solvent B (acetone:ethanol:water:acetic acid,
50:38:11:1 [v/v]) before loading on a reverse-phase C18 column.
For controls, 5 lM BV IXa, BR IXa, or hemin in 500 mL of 50-mM
HEPES–NaOH buffer (pH 7.5) was diluted 2-fold with solvent B.
The solvent systems used were water (solvent A) and solvent B.
The 20-lL mixture was loaded at a concentration of 50% solvent
B and 50% water for 2 min. A linear gradient was then applied from
50% to 100% solvent B over 30 min followed by 100% solvent B for 40
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Fig. 4. Spectrophotometric assay of the time course of the PfHO-catalyzed activity
of hemin. PfHO-catalyzed activity of hemin was followed spectrophotometrically
using both TeFd1 and PfFd. Time-dependent absorbance changes were monitored
during the PfHO reaction after the addition of TeFd1 or PfFd. The arrows indicate the
direction of absorbance changes during the incubation. Control reaction included
PfHO (10 lM), hemin (5 lM) or BV IXa (5 lM), deferoxamine (2 mM), NADPH
(50 lM), TeFNR (7.2 nM), G6P (1 mM), and G6PDH (0.5 units). (A) Control
reactants + TeFd1 (2.4 lM). Inset, magniﬁed view (500–800 nm). (B) Control
reactants + PfFd (2.4 lM). Inset, BVR activity of PfHO as a function of time. The
spectral changes closely resemble the spectral changes observed during the
formation of BR IXa from heme in the presence of HO and BVR. The Soret band
decreases with time, while the bands at approximately 450 and 680 nm appear and
increase. TeFd1 and PfFd support PfHO activity in a different manner. Asterisks
indicate a and b bands of the ferrous dioxyheme complex. (C) Absorbance changes
during the reduction of BV IXa to BR IXa by PfHO with reduced PfFd are depicted.
Inset, the observed absorbance before and after Fd addition.3. Results
3.1. Identiﬁcation, cloning, and expression of PfHO
The physiological activity of the plant homologs of PfHO is to
catalyze heme degradation using the electron transfer reaction
with reduced Fd. To test for such activity, I used Fd1 of the thermo-
philic cyanobacteria T. elongatus BP-1 (gene essential for photosyn-
thesis, TeFd1) and the apicoplast-localized Fd of the human
malaria parasite P. falciparum (apicoplast electron transfer partner,
PfFd).
Ho is a highly conserved gene identiﬁed in various organisms
including mammals, cyanobacteria, and higher plants; all these
organisms possess the BR and/or phycobilin synthesis pathway.
More recently, I identiﬁed a poorly conserved HO and Clostridium
acetobutylicum archaeal-type Fe–S oxidoreductase (CaFeOR) homo-
log from the P. falciparum 3D7 genome data base (PlasmoDB) [10],
which contains the entire putative PfHO sequence; this sequence is
identiﬁed by the existence of the conserved amino acid sequence
AHAY, which includes the essential histidine residue [11] in vari-
ous HOs (Fig. 1).
I identiﬁed a sequence homologous to HO from the P. falciparum
genome database that contained the entire mature PfHO sequence
and part of the N-terminal apicoplast-targeting sequence. The lat-
est release of plasmoDB (version 5.4) contains a protein coding re-
gion, which contains the entire P. falciparum HO sequence,
including its complete N terminus region with the predicted signal
peptide (Fig. 1). In addition, the transit peptide region of PfHO tar-
gets the protein to the mitochondrion, as predicted by TargetP.
The putative mature form of PfHO was overexpressed as a His6-
tagged protein. The analysis of E. coli cell extracts revealed that
only part of the synthesized PfHO was in the soluble fraction.
The protein was puriﬁed aerobically using a BD TALON superﬂow
column that speciﬁcally retains proteins containing a histidine
cluster (Supplementary material). Although the puriﬁed recombi-
nant PfHO was found to be soluble and active, the puriﬁed en-
zymes thus obtained were prone to precipitation and underwent
proteolysis during storage. Despite the low expression level of this
protein, a one-step procedure provided 0.25 mg of puriﬁed enzyme
per liter of culture.
3.2. Heme binding to HO
A characteristic of HO is its ability to form a stable complex with
the substrate heme. To determine whether recombinant PfHO
could form such a complex, PfHO was incubated with heme and
changes in the absorption spectrum were recorded. The change
in the absorption spectrum on formation of the heme–PfHO com-
plex is depicted in Fig. 2. This spectrum change is typically ob-
served during hemoprotein formation; the Soret maximum was
observed at 410 nm, which is similar to the observations for
heme–HO complexes. The inset in Fig. 2 illustrates the obtained
titration plots. It clearly indicates that PfHO binds with heme stoi-
chiometrically. The titration of PfHO with hemin was followed by
observing the absorbance changes at 402 nm. The calculated Kd
was approximately 6.25 lM.
3.3. Absorption spectral evidence for heme degradation activity and
bilins synthesis
To conﬁrm that PfHO is a HO, I followed the reaction spectro-
photometrically (Figs. 3 and 4). Incubation of PfHO and heme with
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Retention time (min)
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Fig. 5. BR IXa is a product of PfHO reaction. PfHO reaction product was analyzed by reverse-phase HPLC. (A) Hemin. (B) BV IXa. (C) BR IXa. (D) End-product of the PfHO
reaction. Absorbance was monitored at 450 nm.
K. Okada / FEBS Letters 583 (2009) 313–319 317reduced Fd resulted in the disappearance of the peak correspond-
ing to the PfHO-heme complex, with a shift of the Soret peak to
402 nm, and the appearance of two peaks with maxima at 536
and 578 nm (Figs. 3C and 4A). These peaks are indicative of a fer-
rous dioxyheme complex as has been observed previously
[6,12,13]. When the iron chelator deferoxamine and Fd were in-
cluded in the assay, a broad peak at approximately 650–690 nm
was observed, indicating the formation of BV IXa (Figs. 3C and
4A). In the absence of the iron chelator, BV IXa formation was
not detected (Fig. 3D).
Both algal [14] and cyanobacterial [15] HOs use Fd as the prin-
cipal reductant. Control experiments in which either the iron che-
lator (Fig. 3D) or Fd (Fig. 3B) was excluded from the reaction did
not result in the appearance of peaks corresponding to the ferrous
dioxyheme complex or BV IXa, indicating that both components
are absolutely essential for the reaction to proceed under these
conditions.
To gain further insight into the function of PfHO in vitro, I
assessed whether puriﬁed recombinant PfFd could drive Fd-
mediated bilins synthesis via heme degradation in the presence
of NADPH and FNR (Fig. 4). Interestingly, an absorption peak at
approximately 450 nm appeared during the reaction with Fd (with
TeFd1 and PfFd; Fig. 4A and B). The spectral shifts depicted in
Fig. 4B closely resembled spectral shifts observed during the
formation of BR IXa from heme in the presence of HO and BVR
[16]. PfHO reduced BV IXa to BR IXa using the reducing equiva-
lents provided by the NADPH/FNR/Fd redox cascade machinery
(Fig. 4C). In the control experiment wherein the iron chelator
was excluded from the reaction (Fig. 3D) BR IXa was not formed.
Fig. 4B shows that the conversion of heme to BR IXa considerably
increased with the addition of PfFd. These results indicate that Fd
can mediate NADPH-driven BR IXa formation by PfHO and support
a role for Fd as the only electron donor in the apicoplast.
3.4. HPLC analysis of the product
To conﬁrm that only BR IXa was produced during the PfHO
reaction, the reaction mixture was analyzed after the completion
of the reaction by HPLC (Fig. 5). The chromatogram obtained for
the product is shown in Fig. 5D. The major peak with a retentiontime of 23.5 min corresponds to authentic BR IXa (Fig. 5C). Chem-
ically synthesized BV IXa was also analyzed (Fig. 5B) and the chro-
matogram for the substrate hemin is shown in Fig. 5A. Therefore,
the ﬁnal product of the PfHO reaction is exclusively BR IXa.4. Discussion
The results of this study demonstrate that the mechanism of
heme cleavage is conserved in the human malaria parasite P. falci-
parum and that heme cleavage results in the production of BR IXa
(Figs. 4 and 5). In addition, PfHO could catalyze the formation of BR
IXa from heme and the obtained absorption spectrum proﬁle was
similar to that obtained with cyanobacterial HO and BVR. This sug-
gests that although the amino acid sequence of PfHO is not very
similar to the HO and BVR sequences, the metabolic conversion
of heme to BR IXa is conserved. Consistent with this, the proximal
heme-binding ligand of plant HO1, His-86 (His-31 in the mature
protein) [5], is not conserved in PfHO (the mature protein is formed
after the cleavage of the signal and transit peptide). The proposed
mechanism of the heme cleavage reaction based on the scheme
proposed for HO and BVR is depicted in Fig. 6.
However, not all aspects of BR IXa synthesis are conserved; one
factor that is highly variable between the different groups of
organisms is the source of reducing equivalents. The mammalian
HO uses NADPH cytochrome P450 reductase as its sole electron
source [17], whereas the plastidial HOs use reduced Fd as the only
electron donor [3,5,14,15]. The mammal and cyanobacterial BVRs
also use NADPH [1,18,19]. To assess whether the malarial and plant
proteins are biochemically conserved, I determined the reductant
requirements for the malarial enzyme. The results demonstrate
that PfHO activity is supported by reduced Fd (Figs. 3 and 4). In
addition, I showed that PfHO activity can be driven directly by Fd
in the presence of NADPH and FNR. The results indicated that
TeFd1 and PfFd support PfHO activity differently. This supports
PfHO activity in different ways. This suggests that Fd is the electron
donor in the apicoplast; however, I cannot rule out other possibil-
ities. The observation that the malarial enzyme uses Fd is consis-
tent with its localization in apicoplasts [9] and it appears that
the use of Fd as an electron donor is conserved in all malaria
NADP+
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Fd ox
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Fig. 6. The proposed mechanism for BR IXa synthesis from heme mediated by PfHO. BR IXa is synthesized from heme via sequential reactions of PfHO. (A) Apicoplast-
localized redox reaction. (B) Reaction intermediates in the PfHO-catalyzed formation of BR IXa from heme.
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targeting signal, it is likely that it may be localized in both the api-
coplast and mitochondrion (unpublished data). My studies reveal
that the apicoplast-localized species is functionally important,
since PfHO utilizes apicoplst Fd for activity. The source of heme
substrate in vivo needs to be established. In the mitochondrion,
PfHOmay use NADPH/FNR/Fd redox cascade machinery having dif-
ferent redox generators, for example, adrenodoxin-type Fd and
FNR-like protein (data not shown).
Another important feature of PfHO is the dependence on an iron
chelator for BR IXa formation. This effect has been observed previ-
ously for the Arabidopsis thaliana HO1 and the iron chelator is be-
lieved to be required for the release of iron from the ferric-BV
complex [5]. In both cases, deferoxamine was found to be the most
effective metal chelator [5,20]. Chelators were not required for the
complete activities of HO1 and HO2 of the cyanobacterium Syn-
echocystis sp. PCC 6803 [3,21]. The strong dependence of PfHO on
iron chelators may be related to the environment in the plastid,
where PfHO is localized. The Fd of human malaria parasites is also
present in plastids [9]. This chelator may also have a role in pro-
moting HO activity in the apicoplast. It is clear that the biochemical
properties of PfHO are well suited to its role as a plastid-localized
enzyme required for the procurement of iron from hemoglobin in
erythrocytes (Supplementary material). However, the signiﬁcance
of these observations in the regulation of HO activity is not yet
clear.
In this study, I identiﬁed PfHO as a novel double-barreled en-
zyme. The results indicate that PfHO is dependent on the
NADPH/FNR/Fd electron ﬂux system as a redox generator. Fd
may function as an efﬁcient electron donor for HO in the relict
plastids (apicoplasts). Other electron carrier proteins probably can-
not function as efﬁcient redox partners for PfHO because the P. fal-
ciparum genome lacks the genes for other electron carrier proteins
such as ﬂavodoxin [22]. At present, I do not know the type of redox
cascade operating for PfHO other than the NADPH/FNR/Fd redox
ﬂux in the apicoplast. Finally, I propose that a novel enzymatic
heme degradation system involving PfHO is present in human ma-
laria parasites ( Supplementary material). It is possible that Fd
might directly reduce BV IXa to BR IXa. BR IXa, which is highly
neurotoxic, causes cerebral palsy with coma as a prominent symp-tom. Thus, cerebral malaria may be due to BR IXa derived from
malarial parasites and accumulated in the brain. Thus, BR may be
a previously unknown malarial toxin (Supplementary material).
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